Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Immunoassay Biomarker Test Menu Expansion Market Size Forecast: How Large Could The Market Become By 2030?
The immunoassay biomarker test menu expansion market has experienced significant growth in recent years. It is projected to expand from $0.53 billion in 2025 to $0.6 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.2%. This historic growth can be attributed to factors such as the increasing prevalence of chronic and infectious diseases, the rising adoption of immunoassay based diagnostic technologies in clinical laboratories, the expansion of hospital diagnostic infrastructure and lab networks, a growing awareness of early disease detection and preventive healthcare, and increasing government funding for diagnostic research and laboratory modernization.
The immunoassay biomarker test menu expansion market size is anticipated to undergo significant growth over the next few years, with projections indicating it will reach $0.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%.
This growth during the forecast period is attributable to an escalating demand for precision medicine and personalized biomarker profiling, increased integration of AI and automation in diagnostic laboratories, the expansion of companion diagnostics within drug development pipelines, rising adoption of multiplex and high-throughput testing platforms, and a growing emphasis on programs for early cancer and chronic disease detection. Key trends in the same period include the broadening of multiplex immunoassay panels for multi-biomarker disease detection, enhanced development of high-sensitivity chemiluminescent immunoassay platforms, increasing uptake of personalized medicine-driven biomarker testing solutions, greater integration of automated laboratory immunoassay analyzers for high-throughput testing, and an escalating demand for expanded oncology and infectious disease biomarker assays.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=73346966&type=smp
Immunoassay Biomarker Test Menu Expansion Market Growth Momentum: Which Factors Are Influencing Demand?
The increasing prevalence of chronic and lifestyle diseases is projected to drive the growth of the immunoassay biomarker test menu expansion market. Chronic and lifestyle diseases are enduring health conditions, including ailments like heart disease, diabetes, obesity, and hypertension, that require continuous medical attention over time. The rise in these diseases is linked to an aging population and lifestyle risk factors such as poor dietary habits and insufficient physical activity, collectively increasing the overall burden of chronic health issues. Expanding the immunoassay biomarker test menu supports improved disease detection by allowing laboratories to identify a wider array of disease-associated biomarkers, thereby enhancing early diagnosis and monitoring. As an illustration, in April 2025, the US Centers for Disease Control and Prevention, a US-based government public health agency, reported that in 2023, 76.4% of US adults, totaling more than 194 million individuals, reported at least one chronic condition requiring regular monitoring and management. Thus, the escalating incidence of chronic and lifestyle diseases is a primary catalyst for the expansion of the immunoassay biomarker test menu market.
Immunoassay Biomarker Test Menu Expansion Market Segment Outlook: Which Categories Are Expanding The Fastest?
The immunoassay biomarker test menu expansion market covered in this report is segmented –
1) By Type: Enzyme-Linked Immunosorbent Assay Kits, Chemiluminescent Immunoassay Kits, Fluorescent Immunoassay Kits, Multiplex Immunoassay Panels, Rapid Diagnostic Test Kits, Biomarker-Specific Reagents, Calibration Standards, Quality Control Materials
2) By Biomarker Type: Oncology Biomarkers, Cardiac Biomarkers, Endocrine And Hormonal Biomarkers, Infectious Disease Biomarkers, Autoimmune Disease Biomarkers, Neurological Biomarkers, Therapeutic Drug Monitoring Biomarkers
3) By Grade: High-Performance Liquid Chromatography (HPLC) And Ultra-High-Performance Liquid Chromatography (UHPLC) Grade Reagents, Gas Chromatography (GC) Grade Reagents, Analytical Grade Reagents, Liquid Chromatography–Mass Spectrometry (LC-MS) Grade Reagents, Preparative Grade Reagents, Biotechnology Grade Reagents, Technical Grade Filtration Products
4) By Application: Clinical Diagnostics, Companion Diagnostics, Personalized Medicine, Drug Discovery And Clinical Research
5) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Contract Manufacturing Organizations, Academic And Research Institutions, Clinical And Diagnostic Laboratories, Food And Beverage Testing Laboratories, Environmental Testing Laboratories, Government And Regulatory Agencies, Chemical And Industrial Manufacturing Companies
Subsegments:
1) By Enzyme-Linked Immunosorbent Assay Kits: Sandwich Assay Kits, Competitive Assay Kits, Indirect Assay Kits, Direct Assay Kits
2) By Chemiluminescent Immunoassay Kits: Magnetic Particle-Based Kits, Solid Phase Kits, Microplate-Based Kits, Automated Analyzer Kits
3) By Fluorescent Immunoassay Kits: Time-Resolved Fluorescence Kits, Lateral Flow Fluorescence Kits, Microbead-Based Kits, Multiplex Fluorescence Kits
4) By Multiplex Immunoassay Panels: Cytokine Panels, Cardiac Marker Panels, Oncology Panels, Infectious Disease Panels
5) By Rapid Diagnostic Test Kits: Lateral Flow Immunoassays, Colloidal Gold Test Kits, Microfluidic Rapid Kits, Paper-Based Diagnostic Kits
6) By Biomarker-Specific Reagents: Antibodies, Antigens, Conjugates, Detection Reagents
7) By Calibration Standards: Protein Standards, Peptide Standards, Whole Blood Controls, Serum Controls
8) By Quality Control Materials: Positive Controls, Negative Controls, Internal Controls, External Controls
Immunoassay Biomarker Test Menu Expansion Market Trends Reshaping Industry Growth
Major organizations operating within the immunoassay biomarker test menu expansion market are focusing on developing advanced automated immunoassay panels. These include fully integrated immunoassay systems designed to streamline sample handling and result reporting within a single automated workflow, with the aim of reducing operator variability and increasing laboratory throughput. Automated immunoassay panels are systems that perform immunoassay tests with minimal manual intervention, employing robotics or automated analyzers to manage sample preparation, reagent mixing, incubation, detection, and result output, thereby improving consistency and turnaround time in clinical settings. For instance, in May 2024, bioMérieux, a France-based healthcare technology company, launched the VIDA TBI (GFAP, UCH-L1) test for its automated immunoassay platforms VIDAS 3 and VIDAS KUBE. This test features high sensitivity for traumatic brain injury biomarkers, is compatible with on-demand automated workflows 24/7, and provides rapid result turnaround, which aids efficient clinical triage and reduces unnecessary imaging. The launch strengthens bioMérieux’s immunoassay test menu by expanding its neurological biomarker portfolio and addressing the growing demand for rapid diagnostic solutions in emergency care settings. Additionally, it supports improved clinical decision-making by enabling timely and accurate detection of brain injury, enhancing patient management, and optimizing healthcare resource utilization.
Immunoassay Biomarker Test Menu Expansion Market Key Companies And Competitive Benchmarking
Major companies operating in the immunoassay biomarker test menu expansion market are Tecan Trading AG, Euroimmun Medizinische Labordiagnostika AG, OPKO Health Inc., Autobio Diagnostics Co. Ltd., Promega Corporation, BioLegend Inc., Sekisui Diagnostics LLC, Boditech Med Inc., Dynex Technologies Inc., QuantuMDx Group Ltd., NanoEntek, J. Mitra & Co. Pvt. Ltd., Baebies, ALPCO Diagnostics, Micropoint Bioscience, Coris BioConcept, MiCo BioMed Inc., Kamiya Biomedical Company, Abionic SA, ANP Technologies Inc., Axis‑Biosciences / Axela, Epitope Diagnostics Inc., MedMira Inc., Nanōmix Inc.
Access The Complete Immunoassay Biomarker Test Menu Expansion Market Report:
Immunoassay Biomarker Test Menu Expansion Market Largest Region By Revenue And Market Share
North America was the largest region in the immunoassay biomarker test menu expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoassay biomarker test menu expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.